Lucy BIZIEN | Institut Imagine

Présentation

Lucy BIZIEN

Génétique humaine des maladies infectieuses

Contact :

01 42 75 44 13

lucy.bizien@institutimagine.org

À propos

Publications scientifiques

Publications

2026

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Pat..., J Infect Dis
2026

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with ..., medRxiv
2026

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephali..., J Hum Immun
2026

An unusual case of RIPK1-related immunodeficiency: The importance of a timely..., Pediatr Allergy Immunol
2025

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes sim..., J Exp Med
2024

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I I..., J Exp Med
2024

A sensitive assay for measuring whole-blood responses to type I IFNs., Proc Natl Acad Sci U S A
2024

Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 o..., J Clin Invest
2024

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-..., J Exp Med
2023

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs n..., Sci Immunol
2023

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis..., J Exp Med
2023

Rare predicted loss-of-function variants of type I IFN immunity genes are ass..., Genome Med
2022

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneu..., J Exp Med
2022

The risk of COVID-19 death is much greater and age dependent with type I IFN ..., Proc Natl Acad Sci U S A
2021

Autoantibodies neutralizing type I IFNs are present in 4% of uninfected indiv..., Sci Immunol
2021

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever..., J Exp Med
2020

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19., Science
2020

Autoantibodies against type I IFNs in patients with life-threatening COVID-19., Science

Faire un don

Présentation

À propos

Publications scientifiques

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Pat..., J Infect Dis

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with ..., medRxiv

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephali..., J Hum Immun

An unusual case of RIPK1-related immunodeficiency: The importance of a timely..., Pediatr Allergy Immunol

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes sim..., J Exp Med

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I I..., J Exp Med

A sensitive assay for measuring whole-blood responses to type I IFNs., Proc Natl Acad Sci U S A

Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB115:02 o..., J Clin Invest*

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-..., J Exp Med

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs n..., Sci Immunol

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis..., J Exp Med

Rare predicted loss-of-function variants of type I IFN immunity genes are ass..., Genome Med

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneu..., J Exp Med

The risk of COVID-19 death is much greater and age dependent with type I IFN ..., Proc Natl Acad Sci U S A

Autoantibodies neutralizing type I IFNs are present in 4% of uninfected indiv..., Sci Immunol

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever..., J Exp Med

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19., Science

Autoantibodies against type I IFNs in patients with life-threatening COVID-19., Science

Présentation

À propos

Publications scientifiques

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Pat..., J Infect Dis

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with ..., medRxiv

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephali..., J Hum Immun

An unusual case of RIPK1-related immunodeficiency: The importance of a timely..., Pediatr Allergy Immunol

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes sim..., J Exp Med

Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I I..., J Exp Med

A sensitive assay for measuring whole-blood responses to type I IFNs., Proc Natl Acad Sci U S A

Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 o..., J Clin Invest

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-..., J Exp Med

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs n..., Sci Immunol

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis..., J Exp Med

Rare predicted loss-of-function variants of type I IFN immunity genes are ass..., Genome Med

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneu..., J Exp Med

The risk of COVID-19 death is much greater and age dependent with type I IFN ..., Proc Natl Acad Sci U S A

Autoantibodies neutralizing type I IFNs are present in 4% of uninfected indiv..., Sci Immunol

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever..., J Exp Med

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19., Science

Autoantibodies against type I IFNs in patients with life-threatening COVID-19., Science

Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB115:02 o..., J Clin Invest*